UNSPSC 51142302: Naloxone

This classification denotes an opiate antagonist with the molecular formula C19H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36B82AMQ7N, chemically known as 17-allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one but generally known as naloxone, which bears US NIH Compound Identifier 5284596. European Medicines Agency schedules Naloxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09142MIG.

UNSPSC 51142302 Naloxone, a Commodity code, encompasses the procurement of naloxone products and related harm-reduction services by state and local health and community agencies. Recent solicitations show two distinct buying patterns: direct product procurement of naloxone units for distribution through public health channels, and contracted training and education services that include naloxone administration instruction and community outreach. State and local governments are buying naloxone as a consumable pharmaceutical supply to support opioid overdose response and community health initiatives, often paired with ancillary services such as drug deactivation systems or educational programming. Issuing bodies under this code include county health departments and community health agencies; the recent record reflects health-focused procurement by county-level agencies rather than school districts, transit authorities, or other municipal departments.

Geographic activity centers on Florida and California, where two recent opportunities were posted in June 2026. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: the posted date and due date show an internal inconsistency in the source). The County of Orange Health Care Agency in California released an RFP on June 29, 2026, for Fentanyl Education and Naloxone Training Services with a total program budget of $700,000 for the initial contract year; questions were due April 2, 2026, and proposals were due April 9, 2026, both at 4:00 p.m. The Orange County opportunity offers local small business and Disabled Veteran Business Enterprise set-asides with a five percent cost deduction, and emphasizes service delivery to underserved populations and higher-risk individuals across adults, families, youth, school staff, law enforcement, and community organizations throughout Orange County.